4.7 Article

Evaluation of Pneumococcal Serotyping of Nasopharyngeal-Carriage Isolates by Latex Agglutination, Whole-Genome Sequencing (PneumoCaT), and DNA Microarray in a High-Pneumococcal-Carriage-Prevalence Population in Malawi

Journal

JOURNAL OF CLINICAL MICROBIOLOGY
Volume 59, Issue 1, Pages -

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.02103-20

Keywords

Streptococcus pneumoniae; serotyping; latex agglutination; microarray; whole-genome sequencing; methodology; Africa

Categories

Funding

  1. Bill and Melinda Gates Foundation, USA [OPP117653]
  2. UK Medical Research Council (MRC)
  3. UK Department for International Development (DFID)
  4. European Union [MR/N023129/1]
  5. Wellcome Trust [106846/Z/15/Z]
  6. Wellcome Trust, UK [206545/Z/17/Z]
  7. UK Government [16/136/46]
  8. NIHR Global Health Research Unit on Mucosal Pathogens
  9. GlaxoSmithKline
  10. Sanofi Pasteur
  11. Pfizer
  12. UK aid from the UK Government [16/136/46]
  13. MRC [MR/N023129/1] Funding Source: UKRI

Ask authors/readers for more resources

The three serotyping methods showed high concordance in identifying dominant serotypes, with latex serotyping being accurate in identifying vaccine serotypes and the microarray capable of detecting additional vaccine serotypes at low relative abundances.
Accurate assessment of the serotype distribution associated with pneumococcal colonization and disease is essential for evaluating and formulating pneumococcal vaccines and for informing vaccine policy. For this reason, we evaluated the concordance between pneumococcal serotyping results by latex agglutination, whole-genome sequencing (WGS) with PneumoCaT, and DNA microarray for samples from community carriage surveillance in Blantyre, Malawi. Nasopharyngeal swabs were collected according to WHO recommendations between 2015 and 2017 by using stratified random sampling among study populations. Participants included healthy children 3 to 6 years old (vaccinated with the 13-valent pneumococcal conjugate vaccine [PCV13] as part of the Expanded Program on Immunization [EPI]), healthy children 5 to 10 years old (age-ineligible for PCV13), and HIV-infected adults (18 to 40 years old) on antiretroviral therapy (ART). For phenotypic serotyping, we used a 13-valent latex kit (Statens Serum Institut [SSI], Denmark). For genomic serotyping, we applied the PneumoCaT pipeline to whole-genome sequence libraries. For molecular serotyping by microarray, we used the BUGS Bioscience Senti-SP microarray. A total of 1,347 samples were analyzed. Concordance was 90.7% (95% confidence interval [Cl], 89.0 to 92.2%) between latex agglutination and PneumoCaT, 95.2% (95% CI, 93.9 to 96.3%) between latex agglutination and the microarray, and 96.6% (95% CI, 95.5 to 97.5%) between the microarray and PneumoCaT. By detecting additional vaccine serotype (VT) pneumococci carried at low relative abundances (median, 8%), the microarray increased VT detection by 31.5% over that by latex serotyping. To conclude, all three serotyping methods were highly concordant in identifying dominant serotypes. Latex serotyping is accurate in identifying vaccine serotypes and requires the least expertise and resources for field implementation and anal ysis. However, WGS, which adds population structure, and microarray, which adds multiple-serotype carriage, should be considered at regional reference laboratories for investigating the importance of vaccine serotypes at low relative abundances in transmission and disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available